15366-62-8 Usage
Uses
Used in Pharmaceutical Industry:
4-Bromonicotinic acid is used as a building block for the synthesis of pharmaceuticals due to its potential anti-cancer, anti-inflammatory, and anti-viral properties. It contributes to the development of new drugs by providing a structural foundation that can be modified to target specific biological pathways.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromonicotinic acid is employed as a precursor in the synthesis of agrochemicals, leveraging its chemical properties to create compounds that can be used in pest control and crop protection.
Used in Organic Chemistry:
4-Bromonicotinic acid is used as a precursor in the production of various organic compounds, where its bromine atom can be replaced or utilized in reactions to form a wide range of chemical products.
Used in Coordination Chemistry:
As a component in the preparation of coordination compounds, 4-Bromonicotinic acid is used to create complexes with metal ions, which have applications in areas such as catalysis, materials science, and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 15366-62-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,3,6 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 15366-62:
(7*1)+(6*5)+(5*3)+(4*6)+(3*6)+(2*6)+(1*2)=108
108 % 10 = 8
So 15366-62-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H4BrNO2/c7-5-1-2-8-3-4(5)6(9)10/h1-3H,(H,9,10)
15366-62-8Relevant academic research and scientific papers
1-(2-PHENOXYMETHYLHETEROARYL)PIPERIDINE AND PIPERAZINE COMPOUNDS
-
Page/Page column 20-21, (2011/10/10)
The invention relates to compounds of formula I: where X, HAr, a, and R1 through R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
